List of Tables
    Table 1. Dermatological Disorders Medications CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
    Table 2. Dermatological Disorders Medications Market Trends
    Table 3. Dermatological Disorders Medications Market Drivers
    Table 4. Dermatological Disorders Medications Market Challenges
    Table 5. Dermatological Disorders Medications Market Restraints
    Table 6. Global Dermatological Disorders Medications Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Dermatological Disorders Medications Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Dermatological Disorders Medications Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Dermatological Disorders Medications Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Dermatological Disorders Medications Manufacturers in Global Market, Ranking by Revenue (2021)
    Table 11. Global Dermatological Disorders Medications Revenue by Manufacturer, (US$ Million), 2017-2022
    Table 12. Global Dermatological Disorders Medications Revenue Share by Manufacturer, 2017-2022
    Table 13. Global Dermatological Disorders Medications Sales by Manufacturer, (K Units), 2017-2022
    Table 14. Global Dermatological Disorders Medications Sales Share by Manufacturer, 2017-2022
    Table 15. Global Dermatological Disorders Medications Price by Manufacturer (2017-2022) & (USD/Unit)
    Table 16. Global Dermatological Disorders Medications Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global Dermatological Disorders Medications by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dermatological Disorders Medications as of 2021)
    Table 18. Top Players of Dermatological Disorders Medications in Global Market, Headquarters and Distribution of Producing Region
    Table 19. Manufacturers Dermatological Disorders Medications Product Type
    Table 20. Date of International Manufacturers Enter into Dermatological Disorders Medications Market
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Top Dermatological Disorders Medications Players in United States Market, Ranking by Revenue (2021)
    Table 23. United States Dermatological Disorders Medications Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 24. United States Dermatological Disorders Medications Revenue Share by Players, 2020, 2021 & 2022
    Table 25. United States Dermatological Disorders Medications Sales by Players, (K Units), 2020, 2021 & 2022
    Table 26. United States Dermatological Disorders Medications Sales Share by Players, 2020, 2021 & 2022
    Table 27. Global Dermatological Disorders Medications Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 28. Global Dermatological Disorders Medications Sales in Volume by Region (2017-2022) & (K Units)
    Table 29. Global Dermatological Disorders Medications Sales in Volume Forecast by Region (2023-2028) & (K Units)
    Table 30. Global Dermatological Disorders Medications Sales in Value by Region (2017-2022) & (US$ Million)
    Table 31. Global Dermatological Disorders Medications Sales in Value Forecast by Region (2023-2028) & (US$ Million)
    Table 32. North America Dermatological Disorders Medications Sales in Volume by Country (2017-2028) & (K Units)
    Table 33. North America Dermatological Disorders Medications Sales in Value by Country (2017-2028) & (US$ Million)
    Table 34. Asia Pacific Dermatological Disorders Medications Sales in Volume by Region (2017-2028) & (K Units)
    Table 35. Asia Pacific Dermatological Disorders Medications Sales in Value by Region (2017-2028) & (US$ Million)
    Table 36. Europe Dermatological Disorders Medications Sales in Volume by Country (2017-2028) & (K Units)
    Table 37. Europe Dermatological Disorders Medications Sales in Value by Country (2017-2028) & (US$ Million)
    Table 38. Latin America Dermatological Disorders Medications Sales in Volume by Country (2017-2028) & (K Units)
    Table 39. Latin Americaa Dermatological Disorders Medications Sales in Value by Country (2017-2028) & (US$ Million)
    Table 40. Middle East and Africa Dermatological Disorders Medications Sales in Volume by Country (2017-2028) & (K Units)
    Table 41. Middle East and Africa Dermatological Disorders Medications Sales in Value by Country (2017-2028) & (US$ Million)
    Table 42. Mylan Pharmaceuticals Corporation Information
    Table 43. Mylan Pharmaceuticals Description and Business Overview
    Table 44. Mylan Pharmaceuticals Dermatological Disorders Medications Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 45. Mylan Pharmaceuticals Dermatological Disorders Medications Product
    Table 46. Mylan Pharmaceuticals Recent Development
    Table 47. Pfizer Corporation Information
    Table 48. Pfizer Description and Business Overview
    Table 49. Pfizer Dermatological Disorders Medications Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 50. Pfizer Product
    Table 51. Pfizer Recent Development
    Table 52. Roche Corporation Information
    Table 53. Roche Description and Business Overview
    Table 54. Roche Dermatological Disorders Medications Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 55. Roche Product
    Table 56. Roche Recent Development
    Table 57. Almirall Corporation Information
    Table 58. Almirall Description and Business Overview
    Table 59. Almirall Dermatological Disorders Medications Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 60. Almirall Product
    Table 61. Almirall Recent Development
    Table 62. Bausch Health Corporation Information
    Table 63. Bausch Health Description and Business Overview
    Table 64. Bausch Health Dermatological Disorders Medications Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 65. Bausch Health Product
    Table 66. Bausch Health Recent Development
    Table 67. Barrier Therapeutics Corporation Information
    Table 68. Barrier Therapeutics Description and Business Overview
    Table 69. Barrier Therapeutics Dermatological Disorders Medications Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 70. Barrier Therapeutics Product
    Table 71. Barrier Therapeutics Recent Development
    Table 72. PharmaDerm Corporation Information
    Table 73. PharmaDerm Description and Business Overview
    Table 74. PharmaDerm Dermatological Disorders Medications Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 75. PharmaDerm Product
    Table 76. PharmaDerm Recent Development
    Table 77. Bristol-Myers Squibb Corporation Information
    Table 78. Bristol-Myers Squibb Description and Business Overview
    Table 79. Bristol-Myers Squibb Dermatological Disorders Medications Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 80. Bristol-Myers Squibb Product
    Table 81. Bristol-Myers Squibb Recent Development
    Table 82. Galderma Corporation Information
    Table 83. Galderma Description and Business Overview
    Table 84. Galderma Dermatological Disorders Medications Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 85. Galderma Product
    Table 86. Galderma Recent Development
    Table 87. GlaxoSmithKline Corporation Information
    Table 88. GlaxoSmithKline Description and Business Overview
    Table 89. GlaxoSmithKline Dermatological Disorders Medications Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 90. GlaxoSmithKline Product
    Table 91. GlaxoSmithKline Recent Development
    Table 92. Novartis Corporation Information
    Table 93. Novartis Description and Business Overview
    Table 94. Novartis Dermatological Disorders Medications Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 95. Novartis Product
    Table 96. Novartis Recent Development
    Table 97. Sinclair Pharma Corporation Information
    Table 98. Sinclair Pharma Description and Business Overview
    Table 99. Sinclair Pharma Dermatological Disorders Medications Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 100. Sinclair Pharma Product
    Table 101. Sinclair Pharma Recent Development
    Table 102. Key Raw Materials Lists
    Table 103. Raw Materials Key Suppliers Lists
    Table 104. Dermatological Disorders Medications Customers List
    Table 105. Dermatological Disorders Medications Distributors List
    Table 106. Research Programs/Design for This Report
    Table 107. Key Data Information from Secondary Sources
    Table 108. Key Data Information from Primary Sources
List of Figures
    Figure 1. Dermatological Disorders Medications Product Picture
    Figure 2. Global Dermatological Disorders Medications Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Dermatological Disorders Medications Market Size 2017-2028 (US$ Million)
    Figure 4. Global Dermatological Disorders Medications Sales 2017-2028 (K Units)
    Figure 5. United States Dermatological Disorders Medications Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 6. United States Dermatological Disorders Medications Market Size 2017-2028 (US$ Million)
    Figure 7. United States Dermatological Disorders Medications Sales 2017-2028 (K Units)
    Figure 8. United States Dermatological Disorders Medications Market Share in Global, in Value (US$ Million) 2017-2028
    Figure 9. United States Dermatological Disorders Medications Market Share in Global, in Volume (K Units) 2017-2028
    Figure 10. Dermatological Disorders Medications Report Years Considered
    Figure 11. Product Picture of Prescription Drugs
    Figure 12. Product Picture of Over-The-Counter Drugs
    Figure 13. Global Dermatological Disorders Medications Market Share by Type in 2022 & 2028
    Figure 14. Global Dermatological Disorders Medications Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 15. Global Dermatological Disorders Medications Sales Market Share in Value by Type (2017-2028)
    Figure 16. Global Dermatological Disorders Medications Sales by Type (2017-2028) & (K Units)
    Figure 17. Global Dermatological Disorders Medications Sales Market Share in Volume by Type (2017-2028)
    Figure 18. Global Dermatological Disorders Medications Price by Type (2017-2028) & (USD/Unit)
    Figure 19. United States Dermatological Disorders Medications Market Share by Type in 2022 & 2028
    Figure 20. United States Dermatological Disorders Medications Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 21. United States Dermatological Disorders Medications Sales Market Share in Value by Type (2017-2028)
    Figure 22. United States Dermatological Disorders Medications Sales by Type (2017-2028) & (K Units)
    Figure 23. United States Dermatological Disorders Medications Sales Market Share in Volume by Type (2017-2028)
    Figure 24. United States Dermatological Disorders Medications Price by Type (2017-2028) & (USD/Unit)
    Figure 25. Product Picture of Hospital Pharmacies
    Figure 26. Product Picture of Online Pharmacies
    Figure 27. Product Picture of Retail Pharmacies
    Figure 28. Global Dermatological Disorders Medications Market Share by Application in 2022 & 2028
    Figure 29. Global Dermatological Disorders Medications Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 30. Global Dermatological Disorders Medications Sales Market Share in Value by Application (2017-2028)
    Figure 31. Global Dermatological Disorders Medications Sales by Application (2017-2028) & (K Units)
    Figure 32. Global Dermatological Disorders Medications Sales Market Share in Volume by Application (2017-2028)
    Figure 33. Global Dermatological Disorders Medications Price by Application (2017-2028) & (USD/Unit)
    Figure 34. United States Dermatological Disorders Medications Market Share by Application in 2022 & 2028
    Figure 35. United States Dermatological Disorders Medications Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 36. United States Dermatological Disorders Medications Sales Market Share in Value by Application (2017-2028)
    Figure 37. United States Dermatological Disorders Medications Sales by Application (2017-2028) & (K Units)
    Figure 38. United States Dermatological Disorders Medications Sales Market Share in Volume by Application (2017-2028)
    Figure 39. United States Dermatological Disorders Medications Price by Application (2017-2028) & (USD/Unit)
    Figure 40. North America Dermatological Disorders Medications Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 41. North America Dermatological Disorders Medications Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 42. U.S. Dermatological Disorders Medications Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 43. Canada Dermatological Disorders Medications Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Europe Dermatological Disorders Medications Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 45. Europe Dermatological Disorders Medications Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 46. Germany Dermatological Disorders Medications Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 47. France Dermatological Disorders Medications Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 48. U.K. Dermatological Disorders Medications Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 49. Italy Dermatological Disorders Medications Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Russia Dermatological Disorders Medications Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Asia-Pacific Dermatological Disorders Medications Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 52. Asia-Pacific Dermatological Disorders Medications Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 53. China Dermatological Disorders Medications Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 54. Japan Dermatological Disorders Medications Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 55. South Korea Dermatological Disorders Medications Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 56. India Dermatological Disorders Medications Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 57. Australia Dermatological Disorders Medications Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 58. Taiwan Dermatological Disorders Medications Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 59. Indonesia Dermatological Disorders Medications Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 60. Thailand Dermatological Disorders Medications Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 61. Malaysia Dermatological Disorders Medications Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 62. Philippines Dermatological Disorders Medications Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 63. Latin America Dermatological Disorders Medications Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 64. Latin America Dermatological Disorders Medications Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 65. Mexico Dermatological Disorders Medications Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 66. Brazil Dermatological Disorders Medications Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 67. Argentina Dermatological Disorders Medications Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 68. Middle East & Africa Dermatological Disorders Medications Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 69. Middle East & Africa Dermatological Disorders Medications Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 70. Turkey Dermatological Disorders Medications Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 71. Saudi Arabia Dermatological Disorders Medications Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 72. U.A.E Dermatological Disorders Medications Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 73. Dermatological Disorders Medications Value Chain
    Figure 74. Dermatological Disorders Medications Production Process
    Figure 75. Channels of Distribution
    Figure 76. Distributors Profiles
    Figure 77. Bottom-up and Top-down Approaches for This Report
    Figure 78. Data Triangulation
    Figure 79. Key Executives Interviewed